Comments
GSK completes trials for combination lung drug
25.08.2012. | LONDON (Reuters) - GlaxoSmithKline has completed final stage testing of its experimental once-daily lung disease drug LAMA/LABA and will press ahead with plans to file for approval of the medicine in global markets from the end of 2012....
